• David Hartell

CNTRP Researchers presenting at the CBMTG


Here is a list of the presentations and posters by CNTRP members at the Annual Conference of the Canadian Blood and Marrow Transplant Group , taking place in Montreal from May 13-16, 2015. You can download a copy of this list here.

Thursday May 14, 2015

Session 1: Canadian Blood and Marrow Transplant Group (CBMTG) – Canadian National Transplant Research Program (CNTRP) Joint Session

9:00AM – 10:00AM

BALLROOM/SALLE DE BAL

CNTRP Update

Marie-Josée Hébert, MD, FRCPC

Renal and Hematopoietic Cell Transplant for Tolerance Induction

Stephan Busque, MD, MSc, FRCSC

Poster Group 1: Clinical Trials and Observations Abstracts

2:45PM – 3:00PM

BALLROOM FOYER/FOYER SALLE DE BAL

Abstract #10

EVALUATION OF ZOSTER PROPHYLAXIS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION USING VALACYCLOVIR FOLLOWED BY VACCINATION

Jamani K, Daly A, Storek J

Session 5: Oral Abstract Presentations

4:45PM – 5:45PM

BALLROOM/SALLE DE BAL

Abstract #1

Donor lymphocytes depleted of alloreactive Tt-cells provide immune protection without causing graft-versus-host disease

Denis-Claude Roy, MD

Abstract #2

Favorable results of haploidentical stem cell transplantation followed by injection of donor T-cells selectively photodepleted of their anti-recipient fraction: interim results from a phase 2 trial in patients with AML, ALL, and MDS

Denis-Claude Roy, MD

Friday May 15, 2015

Poster Group 2: Clinical Trials and Observations Abstracts

10:00PM – 10:15PM

BALLROOM FOYER/FOYER SALLE DE BAL

Abstract #11

OUTCOMES OF MATCHED RELATED AND UNRELATED BONE MARROW TRANSPLANTATION AFTER REDUCED-TOXICITY CONDITIONING FOR CHILDREN SUFFERING FROM CHRONIC GRANULOMATOUS DISEASE

Teira P, Cros G, Bittencourt H, Cellot S, Vachon M-F, Decaluwe H, Duval M, Haddad E

Abstract #12

TO PARTNER WITH PATIENTS TO IMPROVE HEMATOPOIETIC CELL TRANSPLANT OUTCOME: IMPLEMENTATION OF A PATIENT PARTNERSHIP PROGRAM WITHIN THE STEM CELL TRANSPLANT UNIT

Grondin F, Séguin-Charbonneau N, Kudelka E, Roger C, Thibault Y, Tremblay N, and Lachance S

Abstract #13

PROPHYLACTIC ANTIBIOTICS AIMING GUT DECONTAMINATION WORSEN ACUTE GRAFT-VERSUS-HOST DISEASE AND SURVIVAL FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Letendre C, Routy B, Mehraj V, Charbonneau Séguin N, Gagnon K, Lachance S

Abstract #14

EVALUATION AND SYSTEMATIC TREATMENT OF PATIENTS WITH CHRONIC GRAFT-VERSUSHOST DISEASE (GVHD) IN A SPECIALIZED MULTIDISCIPLINARY OUTPATIENT CLINIC: A 5-YEAR EXPERIENCE

Nair A, Nevill T, Toze C, Hogge D, Gerrie A, Song K, Abou Mourad Y, Sutherland H, Narayanan S, Power M, Nantel S, Barnett M, Forrest D and Broady R

Abstract #17

IMPACT OF CIPROFLOXACIN PROPHYLAXIS ON ANTIMICROBIAL RESISTANCE IN NEUTROPENIC LEUKEMIA/STEM CELL TRANSPLANT PATIENTS

Warkentin D, PharmD, Mach A, Lacaria K, Roscoe D, Lau T, Bowie W, and Broady R

Clinical Trials Network and BMT Registry Meeting

3:30pm – 5:00pm

BALLROOM/SALLE DE BAL

Chairs: Kristjan Paulson, MD, Donna Wall, MD


8 views
  • Black Facebook Icon
  • Black Twitter Icon
  • Black YouTube Icon

© 2014 by the CDTRP

All rights reserved